Japan, March 3 -- AMGEN has got intellectual property rights for 'MCL-1 INHIBITOR FORMULATIONS.' Other related details are as follows:
Application Number: JP,2021-127983
Category (FI): A61K31/498,A61K31/553,A61K47/10,A61K47/26,A61K47/32,A61K47/34,A61K47/36,A61K47/38,A61K9/20,A61P35/00,A61P35/02
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Aug. 4, 2021
Publication Date: March 10, 2022
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
